Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results

Go back to Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
(NYSE: GNMX) Delayed: 35.84 +0.71 (2.02%)
Previous Close $35.13    52 Week High
Open $35.46    52 Week Low
Day High $35.84    P/E N/A 
Day Low $35.46    EPS
Volume 940